An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
Top Cited Papers
Open Access
- 1 March 2007
- journal article
- review article
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 5 (1), 19-34
- https://doi.org/10.3121/cmr.2007.698
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs), including both traditional nonselective NSAIDs and the selective cyclooxygenase (COX)-2 inhibitors, are widely used for their anti-inflammatory and analgesic effects. NSAIDs are a necessary choice in pain management because of the integrated role of the COX pathway in the generation of inflammation and in the biochemical recognition of pain. This group of drugs has recently come under scrutiny because of recent focus in the literature on the various adverse effects that can occur when applying NSAIDs. This review will provide an educational update on the current evidence of the efficacy and adverse effects of NSAIDs. It aims to answer the following questions: (1) are there clinically important differences in the efficacy and safety between the different NSAIDs, (2) if there are differences, which are the ones that are more effective and associated with fewer adverse effects, and (3) which are the effective therapeutic approaches that could reduce the adverse effects of NSAIDs. Finally, an algorithm is proposed which delineates a general decision-making tree to select the most appropriate analgesic for an individual patient based on the evidence reviewed.Keywords
This publication has 99 references indexed in Scilit:
- Acetaminophen for osteoarthritisEmergencias, 2006
- Long-term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intoleranceAnnals of Allergy, Asthma & Immunology, 2005
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialThe New England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionThe New England Journal of Medicine, 2005
- Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac SurgeryThe New England Journal of Medicine, 2005
- Tolerability of Selective Cyclooxygenase Inhibitor, Celecoxib, in Patients with Analgesic IntoleranceJournal of Asthma, 2005
- Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-Counter DosesJournal of International Medical Research, 2002
- Update of ACR Guidelines for Osteoarthritis: Role of the CoxibsJournal of Pain and Symptom Management, 2002
- Onset of Analgesia for Liquigel Ibuprofen 400 mg, Acetaminophen 1000 mg, Ketoprofen 25 mg, and Placebo in the Treatment of Postoperative Dental PainThe Journal of Clinical Pharmacology, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000